China Universal Asset Management »

Arbutus Biopharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $83k 32k 2.58
2023-12-31 $49k 19k 2.53
2023-09-30 $9.0k 4.3k 2.10
2023-06-30 $5.0k 2.2k 2.30
2023-03-31 $6.0k 2.1k 2.83
2022-12-31 $4.0k 1.6k 2.52
2022-09-30 $3.0k 1.4k 2.14

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Arbutus Biopharma

Whitefort Capital Management
Vanguard Group
Hudson Bay Capital Management
ADAR1 Capital Management
Centiva Capital
Citadel Advisors
Millennium Management
Advisor Group Holdings
FourWorld Capital Management
Citigroup
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Barclays
Bank Of Montreal

View all funds holding Arbutus Biopharma